Cellebrite DI (CLBT) Shares Outstanding (2020 - 2026)

Cellebrite DI has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $249.4 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 4.16% year-over-year to $249.4 million in Q4 2025; TTM through Dec 2025 was $249.4 million, a 4.16% increase from a year earlier, with the FY2025 full-year figure at $249.4 million, up 4.16% from the prior year.
• Shares Outstanding (Entity) was $249.4 million for Q4 2025 at Cellebrite DI, up from $239.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $249.4 million in Q4 2025, with the low at $124.7 million in Q4 2021.
• Average Shares Outstanding (Entity) over 5 years is $202.7 million, with a median of $205.3 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) changed 0.0% in 2021, then jumped 56.16% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $124.7 million in 2021, then soared by 56.16% to $194.7 million in 2022, then climbed by 5.45% to $205.3 million in 2023, then advanced by 16.65% to $239.5 million in 2024, then grew by 4.16% to $249.4 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $249.4 million (Q4 2025), $239.5 million (Q4 2024), and $205.3 million (Q4 2023), per Business Quant data.